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Purpose: The aim of this study was to analyze the results of children treated with 
hemodialysis (HD) at Severance Hospital over 35 years in terms of incidence, etiol-
ogies, characteristics, complications, and clinical outcomes. Materials and Meth-
ods: We analyzed 46 children admitted to Severance Hospital who had undergone 
HD between January 1979 and December 2013. Results: The main etiologies of 
the 23 end-stage renal disease (ESRD) patients who had received HD were chronic 
glomerulonephritis (7 patients, 30.4%) and congenital anomalies of the kidney and 
urinary tract (7 patients, 30.4%), whereas the etiology of the 23 acute kidney injury 
(AKI) patients was hemolytic uremic syndrome (6 patients, 26.1%). Compared 
with ESRD patients, hemocatheter placement in the femoral vein was preferred 
over the subclavian or internal jugular vein in the AKI patients (p=0.012). The most 
common complication was catheter related complication (10 patients, 21.7%). The 
site of hemocatheter insertion was not related to the frequency of oozing. Placing 
the hemocatheter in the femoral vein resulted in significantly more events of cathe-
ter obstruction than insertion in the internal jugular vein or the subclavian vein 
(p=0.001). Disequilibrium syndrome occurred more frequently in older patients 
(p=0.004), as well as patients with a greater body weight (p=0.008) and a higher 
systolic and diastolic blood pressure before HD (systolic: p=0.021; diastolic: 
p=0.040). Conclusion: Based on the 35 years of experience in our center, HD can 
be sufficiently and safely carried out even in children without significant complica-
tions.
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INTRODUCTION
End-stage renal disease (ESRD) is the terminal stage of chronic kidney disease 
(CKD), and renal replacement therapy (RRT) is necessary to sustain life among 
ESRD patients who are awaiting kidney transplantation (KT).1 Acute kidney injury 
(AKI) is a rapid and reversible deprivation of kidney function, leading to retention 
of fluid and nitrogenous wastes and derangement of acid-base balance and electro-
lytes.2 As the prevalence of ESRD and AKI patients requiring RRT has recently in-
creased, access to various renal replacement modalities such as peritoneal dialysis 
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The following information was collected for all patients: 
age at the commencement of HD, body weight, body weight 
change after HD, gender, frequency of HD sessions, dura-
tion of the first HD session, reason for receiving HD, reason 
for selecting HD as a RRT modality, site of initial vascular 
access, complications during HD, symptoms during HD, 
kinds of anti-coagulants during HD, prognosis of the pa-
tients, and laboratory investigations [complete blood count, 
initial (pre-HD) blood urea nitrogen (BUN), post-HD BUN, 
reduction ratio of BUN after HD, electrolytes before and af-
ter the first HD session, and blood pressure before and after 
the first HD session]. We calculated the BUN reduction ratio 
with the BUN before and after HD in patients according to 
the following equation: BUN reduction ratio=100×(pre-HD 
BUN-post-HD BUN/pre-HD BUN). HD was prescribed 
three to four times per week and lasted 2‒4 hours per ses-
sion. The blood flow rate (BFR) is usually described as 
“mL/min” in adults; however, as our patients included both 
small and large children, we described it as “mL/kg/min” for 
accurate analysis. The model of the infant dialysis machine 
was not available before 2005. After the year 2005, HD was 
performed with Fresenius Medical Care 4008-S machines 
and Helixone dialysis filters (Fx paed®, Fresenius, Bad 
Homburg, Germany).
Results were evaluated using frequencies and percentages 
for categorical variables and means with standard deviation 
or median with ranges for continuous variables. Data were 
analyzed with a t-test, a chi-square test, Fisher’s exact test, 
or the Mann-Whitney U test, using SPSS software (version 
20.0, SPSS Inc., Chicago, IL, USA) for Windows. A p-val-
ue<0.05 was considered statistically significant.
RESULTS
Patient characteristics
From January 1979 to December 2013 a total of 54 patients 
who were younger than 18 years were found to have been 
treated with HD. Among these patients, 46 (29 male, 63.0%; 
17 female, 37.0%) had sufficient data for analysis in this 
study. The number of patients receiving HD increased sig-
nificantly after the year 2000, which was dependent on the 
increasing application of HD due to improving technology 
(Fig. 1).
Patients were divided into two groups depending on the 
reason for HD: ESRD (23 patients, 50%) and AKI (23 pa-
tients, 50%). The main etiologies for HD among ESRD pa-
(PD), hemodialysis (HD), and continuous hemodiafiltration 
has improved accessibility for the treatment of pediatric pa-
tients with ESRD and AKI.1
Among dialysis modalities, PD is preferred in young chil-
dren with ESRD due to better hemodynamic stability and 
more preservation of residual renal function.1,3 However, 
HD is also used as a short-term bridge to renal transplanta-
tion or in situations when PD cannot be carried out for vari-
ous reasons.4-6 In children with AKI, the application of con-
tinuous hemodiafiltration is recently increasing, as strict 
volume control and better nutritional support are possible.7 
However, given that continuous hemodiafiltration is usually 
performed in the intensive care unit (ICU), HD can be ap-
plied in less severe AKI children, who do not need to admit-
ted to the ICU.
HD has been used in pediatric patients since the 1950s.8 
Over the past decade, the proportion of pediatric patients re-
ceiving HD as RRT has gradually increased as equipment 
and techniques for HD have improved, even for small chil-
dren.9 However, there have been very few data on HD in pe-
diatric patients despite the increasing frequency of HD.10 
The first usage of HD on a pediatric patient in Korea was 
performed at our center in 1979 on a 13-year-old boy with 
ESRD caused by vesicoureteral reflux, who was treated for 
one month before renal transplantation.11 For the continued 
development of HD as an optimal renal replacement thera-
peutic modality in pediatric patients, accurate data are re-
quired based on long-term experience.3
The purpose of our study was to review the data of pedi-
atric patients treated with HD at Severance Hospital over 
the last 35 years in terms of incidence, etiologies, character-
istics, complications, and clinical outcomes.
MATERIALS AND METHODS
Data from all patients who had received HD at Severance 
Hospital in South Korea from January 1979 to December 2013 
were retrospectively reviewed. Ages of all patients were 18 
years or less at the commencement of HD. We identified 54 
children admitted to Severance Hospital who had undergone 
HD during the study period. Among them, 46 patients with 
available medical records were retrospectively reviewed. 
These 46 patients were divided into two groups according to 
reasons for receiving HD: AKI and ESRD. Patients were 
followed until death, renal transplantation, withdrawal from 
dialysis, or recovery of renal function.
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an 13.0 sessions) in ESRD patients and 2.2±0.6 sessions 
(range 1‒30 sessions) in AKI patients. The mean duration of 
the first HD session in the ESRD patient group was 2.1±0.9 
hours (range 2‒4 hours, median 2.0 hours) and 2.2±0.6 
hours (range 1.5‒4 hours, median 2.3 hours) in the AKI 
group. We determined that the duration of the first dialysis 
session was relatively shorter than the duration of mainte-
nance HD in order to prevent the occurrence of disequilibri-
um syndrome and to allow patients to adapt to solute remov-
al and ultrafiltration. The mean age at the time of HD 
initiation was 10.1±4.6 years old (range 1.1‒18.0) in ESRD 
patients and 8.4±5.2 years old (range 1.7‒18.0) in AKI pa-
tients. There was a statistically significant difference of onset 
age between AKI and ESRD patients (p=0.002). Grouping 
by age distribution, the age group including patients 5 to 9 
years old was most dominant among ESRD patients (9 pa-
tients, 39.1%), and those 0 to 4 years old were the largest age 
group among AKI patients (10 patients, 43.4%). When onset 
age was divided into groups, there was no statistical differ-
ence between AKI and ESRD patients (p=0.073).
The average weight of patients at the time of HD therapy 
was 24.5±16.1 kg (range 9.4‒52.3 kg) in the ESRD patient 
group and 31.3±19.4 kg (range 11.8‒71.0 kg) in AKI pa-
tients. There was no statistical difference in body weight 
between the two groups (p=0.391) (Table 1). The BFR de-
tients were chronic glomerulonephritis [7 patients, 30.4%: 
focal segmental glomerulosclerosis (4 patients), lupus ne-
phritis (1 patient), IgA nephritis (1 patient), and IgM nephri-
tis (1 patient)] and congenital anomalies of the kidney and 
urinary tract (CAKUT) [7 patients, 30.4%: vesicoureteral re-
flux (3 patients), dysplastic or hypoplastic kidney (3 pa-
tients), and polycystic kidney (1 patient)]. On the other 
hand, the most common cause of AKI was hemolytic ure-
mic syndrome (6 patients, 26.1%). Other etiologies of each 
group are described in Table 1.
The average frequency of whole HD sessions per each pa-
tient was 213.4±74.9 sessions (range 2‒997 sessions, medi-
Fig. 1. Incidence of acute kidney injury and end-stage renal disease for pa-
tients who received HD during a 35-year period at Severance Hospital. AKI, 
acute kidney injury; ESRD, end-stage renal disease; HD, hemodialysis.
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Table 1. Clinical Characteristics of 46 Patients on Hemodialysis
Characteristics
Groups
p value
AKI (n=23) ESRD (n=23)
Age at onset (range) 8.4±5.2 yrs (1.7‒18.0) 10.1±4.6 yrs (1.1‒18.0) 0.002
Sex (%) 0.371
Male 13 (56.5) 16 (69.6)
Female 10 (43.4) 7 (30.4)  
Body weight (range) 31.3±19.4 kg (11.8‒71.0) 24.5±16.1 kg (9.4‒52.3) 0.391
Etiology (%)
Hemolytic uremic syndrome 6 (26.1) 0 (0)
Glomerulonephritis 4 (17.4) 7 (30.4)
Post-renal after ureteroneocystostomy 3 (10.3) 0 (0)
Drug induced 2 (8.7) 0 (0)
Chemotherapy induced 0 (0) 1 (4.3)
Nephrotic syndrome 1 (4.3) 1 (4.3)
Sepsis 2 (8.7) 0 (0)
Tumor lysis syndrome 1 (4.3) 0 (0)
Cardiogenic shock 2 (8.7) 0 (0 )
Bilateral Wilm’s tumor 0 (0) 2 (8.7)
CAKUT 0 (0) 7 (30.4)
Renal tubular acidosis 0 (0) 1 (4.3)
Unknown 2 (8.7) 4 (17.4)
AKI, acute kidney injury; ESRD, end-stage renal disease; CAKUT, congenital anomalies of the kidney and urinary tract.
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nafamostat was administrated to 1 patient (2.2%), both as an-
ti-coagulation drugs for the maintenance of the catheter. One 
patient with nafamostat in the ESRD group showed dissemi-
nated intravascular coagulation. Every patient used heparin at 
the end of whole sessions of HD. Except for 8 patients who 
had bleeding tendencies, administrations of anti-coagulants 
at the first session of HD were followed by the preference of 
nephrologists.
Complications of HD
The most common type of complication of HD among all 
46 patients was a catheter-related complication (10 patients, 
21.7%) followed by disequilibrium syndrome (9 patients, 
20.0%). The remaining 27 patients had no significant com-
plications, such as disequilibrium syndrome, catheter-related 
complications, electrolyte imbalance, cardiac problems, or 
hypotension.
The most frequent catheter-related complication during 
HD was oozing (4 patients, 8.7%), followed by obstruction 
(3 patients, 6.5%) and line extrusion (2 patients, 4.3%). 
Only one patient (2.2%) had a catheter-related infection. The 
site of hemocatheter insertion was not significantly related 
to oozing; however, a hemocatheter placed in the femoral 
vein had significantly more events of catheter obstruction 
than those inserted in the internal jugular vein or the subcla-
vian vein (p=0.001).
At our center, 9 patients presented symptoms of disequilib-
rium syndrome. This complication occurred more frequently 
in older patients (no symptoms: 8.2±5.0 years; symptoms: 
12.2±2.9 years; p=0.004), patients with a greater body 
weight (no symptoms: 27.2±2.8 kg; symptoms: 44.1±15.3 
kg; p=0.008), and those with a greater change in body weight 
after HD (no symptoms: 0.5±0.3 kg; symptoms: 1.4±0.1 kg; 
p=0.037). However, there were few data for body weight af-
ter HD (13 patients with no symptoms and 4 patients with 
symptoms). Furthermore, patients with a higher systolic 
blood pressure (no symptoms: 123.0±15.6 mm Hg; symp-
toms: 140.1±21.6 mm Hg; p=0.021) and diastolic blood 
pressure (no symptoms: 74.3±13.9 mm Hg; symptoms: 
85.7±16.3 mm Hg; p=0.040) before HD more commonly 
showed disequilibrium syndrome. In addition, as the defini-
tion of hypertension (HTN) is different for all ages and gen-
ders in children and adolescents, we attempted to categorize 
the blood pressures (BPs) of our patients according to the 
Fourth Report of National High Blood Pressure Education 
Program Working Group on High Blood Pressure.12 Addi-
tionally, we studied correlations between the age-specific 
pends on the body weight and blood pressure of the patient, 
as vital signs of small and hypotensive children could change 
easily according to relatively small changes of body volume 
upon initial HD; additionally, small children have small-size 
hemocatheters, which cannot endure a high BFR. In our re-
port, the mean BFR was 5.1±2.4 mL/kg/min (3.0‒10.7 mL/
kg/min) (Table 2).
Hemocatheters were inserted for vascular access for all 
patients. The most commonly used site for the hemocatheter 
was the internal jugular vein (24 patients, 52.2%), followed 
by the subclavian vein (13 patients, 28.3%) and the femoral 
vein (9 patients, 19.5%). In contrast to ESRD patients, he-
mocatheter placement in the femoral vein was preferred 
over the subclavian or internal jugular vein in AKI patients 
(p=0.012). Among the ESRD patients, a hemocatheter was 
changed to an arteriovenous fistula (AVF) in 3 patients and to 
a permanent catheter in 14 patients for maintenance of HD. 
The permanent catheter was flushed with heparin (1000 IU) 
to maintain patency between each HD session. AVF forma-
tions were performed in 3 children. One patient needed long-
term HD due to rejection after KT. Two boys needed long-
term HD until they found suitable kidney donors, as they did 
not have available kidney donors in their family. In the first 
HD session, heparin was used for 17 patients (37.0%), and 
Table 2. Laboratory Characteristics and Blood Pressure of 
46 Patients on Hemodialysis
Characteristics Values
Time for HD session (range) 2.22±0.7 hrs (1 to 4)
Anticoagulation during HD (n)
Heparin (%) 17 (37.0)
Nafamostat (%) 1 (2.2)
None (%) 28 (60.9)
Blood flow rate on HD (mL/kg/min) 5.1±2.4 (3.0 to 10.7) 
Blood urea nitrogen
Before HD (mg/dL) 74.6±40.8 
After HD (mg/dL) 44.3±28.1 
Urea nitrogen reduction ratio (%) 34.6±18.3
Initial electrolytes before HD (serum) 
Na (mmol/L) 135.9±4.8
K (mmol/L) 4.2±1.1
Cl (mmol/L) 97.3±11.5
Tco2 (mmol/L) 20.7±5.2
Blood pressure
Systolic (pre-HD) (mm Hg) 126.4±20.2
Diastolic (pre-HD) (mm Hg) 76.6±14.9
Systolic (post-HD) (mm Hg) 123.4±22.6
Diastolic (post-HD) (mm Hg) 73.6±14.8
HD, hemodialysis.
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who progressed to ESRD switched from HD combined with 
continuous hemodiafiltration to PD (HD duration: 3 days). 
Three children (6.5%) expired during the observation period 
(2 AKI patients and 1 ESRD patient). The causes of death 
were septic shock in 1 AKI patient (expired 7 days after start-
ing HD), aggravating disseminated intravascular coagula-
tion in 1 AKI patient (expired 25 days after starting HD), 
and uremic cardiomyopathy in 1 ESRD patient (expired 5 
years after starting HD).
DISCUSSION
The outlook for pediatric patients with RRT has notably im-
proved over the last 20 years.13 As a consequence, the num-
ber of pediatric HD patients has increased since the first pe-
diatric HD at our center in 1979.11 In fact, the proportion of 
those younger than 5 years old has particularly increased 
HTN and frequency of disequilibrium syndrome occurrenc-
es. We found that patients with age-specific higher systolic 
and diastolic BPs before HD more commonly presented dis-
equilibrium syndrome, with the results showing statistical sig-
nificance (p=0.013). However, there was no statistical signifi-
cance in a multivariate analysis comparing age, weight, BFR, 
systolic blood pressure before HD, and diastolic blood pres-
sure before HD with the occurrence of disequilibrium syn-
drome (Table 3).
Outcomes
Among the 23 patients with ESRD, 11 patients received KT 
and 11 were switched to PD for maintenance of RRT. The 
average periods of dialysis were 61.8±99.0 days (median 58 
days) before KT and 36.7±25.7 days (median 30 days) be-
fore conversion to PD.
Among 23 patients with AKI, 20 patients recovered from 
AKI status (30.4±29.1 days, median 24 days), and 1 patient 
Table 3. Risk Factors for Disequilibrium Syndrome
Disequilibrium syndrome
p value
No symptoms (n=37) Symptoms (n=9)
Age (yrs) 8.2±5.0 12.2±2.9 0.004
Weight (kg) 27.2±2.8 44.1±15.3 0.008
Blood flow rate (mL/kg/min) 5.5±2.5 3.8±1.3 0.327
Weight change after HD (kg) 0.5±0.3* 1.4±0.1† 0.037
First HD session time (hrs) 2.0±0.8 2.5±0.8 0.184
Blood urea nitrogen
Before HD (mg/dL) 73.0±6.8 81.0±39.3 0.605
After HD (mg/dL) 43.9±30.4 45.9±17.1 0.855
Reduction ratio (%) 33.4±18.9 39.8±15.5 0.351
Electrolyte before HD
Na (mmol/L) 136.1±4.4 135.1±6.3 0.601
K (mmol/L) 4.7±1.1 3.9±0.9 0.394
Cl (mmol/L) 99.0±5.5 90.1±23.2 0.284
Tco2 (mmol/L) 20.8±5.1 20.1±6.0 0.711
Blood pressure (mm Hg)
Systolic (pre-HD) 123.0±15.6 140.1±21.6 0.021
HTN by age-specific criteria (n) 21 (56.8%) 9 (100.0%) 0.013
Diastolic (pre-HD) 74.3±13.9 85.7±16.3 0.040
HTN by age-specific criteria (n) 21 (56.8%) 9 (100.0%) 0.013
Systolic (post-HD) 121.5±22.3 130.9±23.6 0.271
HTN by age-specific criteria (n) 19 (51.3%) 7 (77.8%) 0.145
Diastolic (post-HD) 72.3±15.5 78.4±10.5 0.272
HTN by age-specific criteria (n) 19 (51.3%) 7 (77.8%) 0.145
Etiology (n)
AKI 17 6
ESRD 20 3 0.265
AKI, acute kidney injury; ESRD, end-stage renal disease; HD, hemodialysis; HTN, hypertension.
*n=13.
†n=4.
Hyun-Seung Shin, et al.
Yonsei Med J   http://www.eymj.org   Volume 56   Number 4   July 20151012
complications associated with HD. This syndrome is char-
acterized by neurologic deteriorations such as headache, 
numbness, restlessness, seizure, or mental status chang-
es.28,29 The causes and risk factors of this syndrome are still 
not exactly known.28,29
Despite the development of HD over the years, the etiolo-
gies and risk factors of this syndrome remain poorly de-
fined, especially in children. Some reports have suggested 
that the risk factors for disequilibrium syndrome were a 
markedly high BUN, a high BUN reduction ratio, CKD 
rather than AKI, metabolic acidosis, pediatric patients, elec-
trolyte imbalances (especially hyponatremia), or pre-exist-
ing central nervous system lesions such as malignant HTN 
before HD.28-31 However, studies on disequilibrium syn-
drome in pediatric patients undergoing HD have not yet 
been published. According to our study, older and heavier 
patients had more frequencies of occurring disequilibrium 
syndrome during HD. Furthermore, patients with high sys-
tolic and diastolic blood pressure before HD also had a 
greater frequency of disequilibrium syndrome during HD. 
Along these lines, Arieff, et al.30,32 reported that patients with 
conditions such as malignant HTN develop cerebral edema 
easier than patients with normal blood pressure, such that 
these patients had a greater tendency to develop disequilibri-
um syndrome during HD. Although our data shows that a 
greater change in body weight after HD can increase the risk 
of disequilibrium syndrome, the small number of data col-
lected is a limitation of this study. In addition, patients with a 
fast BFR (described as “mL/min”) upon HD had a higher 
frequency of disequilibrium syndrome in our study. This re-
sult was consistent with the report from Bagshaw, et al.31 
and Flannery, et al.33 that reducing the blood flow rate during 
HD lowered the rate of disequilibrium syndrome. However, 
when we described BFR as including body weight (mL/kg/
min), it did not correlate with the frequency of disequilibri-
um syndrome. Future large-scale, long-term studies will be 
required to elucidate the pathophysiology behind this phe-
nomenon.
Lastly, the BUN reduction ratio, BUN levels before and 
after HD, and the use of mannitol were not statistically relat-
ed to the occurrence of disequilibrium syndrome in our 
study. Our center prescribed the first HD to patients as a 
goal of reducing BUN concentration by less than 40% in or-
der to prevent disequilibrium syndrome, as some reports 
about disequilibrium syndrome had indicated.28,29 As a result 
of our analysis, we could not conclude that a high BUN re-
duction ratio was a risk factor in disequilibrium syndrome.
since the year 2000. In addition, the mortality of pediatric 
ESRD patients on HD was very low: only one patient (4.3%) 
died during the HD treatment period at our center. Accord-
ing to reports from other countries, the mortality rate of pe-
diatric ESRD patients on HD is 4.2‒26.7%,14-16 and the main 
cause of mortality in pediatric patients is cardiovascular dis-
ease.14,17 In our center, we observed only one patient who died 
due to uremic cardiomyopathy.
CAKUT is the main etiology of CKD (34‒43%) among 
pediatric ESRD patients in developed countries, such as Eu-
rope, Japan, Australia, New Zealand, and the United States,18-20 
whereas chronic glomerulonephritis is the main cause of 
CKD in various other countries and regions such as India, 
Latin America, Southeast Asia, and sub-Saharan Africa 
(30‒60%).21-24 In our center, glomerulonephritis and CAKUT 
occurred with the same frequency (30.4% each) as the lead-
ing causes of CKD.
The most common etiology of AKI at our center was he-
molytic uremic syndrome (6 patients, 26.1%) and glomeru-
lonephritis (4 patients, 17.4%). Regarding the etiologies of 
AKI, our center showed a changing trend from hemolytic 
uremic syndrome and glomerulonephritis in the 1980s to 
acute tubulonephritis, congenital heart disease, and nephro-
toxic medications in the 2010s, similar to other studies.1,25 
At our hospital, a double-lumen, un-cuffed hemocatheter 
was the first choice for children on short-term and long-term 
HD. The rate of catheter-related complications was very low 
at our center. Such remarkable results could be attributed to 
the performance of skillful doctors with radiologic devices 
such as ultrasonography and C-arm, as well as systematic 
aseptic catheter management. Moreover, the insertion site of 
the hemocatheter had no impact on the frequency of cathe-
ter-related oozing in our study. However, hemocatheters 
placed in the femoral vein had significantly more obstruc-
tion events than those placed in the internal jugular vein or 
the subclavian vein.
Current guidelines from Europe and the United States on 
vascular access for long-term HD suggest that an AVF 
should be considered in pediatric patients rather than a he-
mocatheter, whereas temporary hemocatheters are the first 
choice for children requiring short-term HD.26,27 In our cen-
ter, only 3 patients had an AVF for long-term HD. The rea-
son for this low number may be due to relatively prompt KT 
from parents, and as a result, there were very few pediatric 
patients who needed a long term maintenance HD, which 
would normally require an AVF formation.
Dialysis disequilibrium syndrome was one of the rare 
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There are some limitations in our study. First, there were 
limitations of the data analysis due to insufficient old data 
and missing data of patients under 1 year old. However, our 
study is the first to describe the etiologies, characteristics, 
complications, and clinical outcomes of pediatric patients on 
HD in Korea and also the first in the world to analyze the 
risk factors of the development of disequilibrium syndrome 
in pediatric patients on HD. Our results demonstrate that 
HD can be sufficiently carried out, even in infants. The 
number of pediatric patients with AKI and ESRD receiving 
HD has recently increased, and outcomes have improved 
significantly. Based on the experience of using HD for chil-
dren at our center, we believe that HD should be more avail-
able to children as a safe modality for RRT. Given that the 
application of HD to small children is not always possible in 
tertiary hospitals in Korea, the transfer of patients who re-
quire HD to available centers may also be necessary.
In conclusion, according to our study, we conclude that 
HD an effective renal replacement modality for pediatric pa-
tients with AKI and ESRD. Further advancements in HD 
techniques will improve the outcomes of HD in pediatric pa-
tients.
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